Products > MolPath > Next Generation Sequencing (NGS) > The AmoyDx®-ddCAP kits (Hybrid Capture)

The AmoyDx®-ddCAP kits (Hybrid Capture)


The protocol of AmoyDx® ddCAP (dual directional capture) kits encompasses a two-day workflow. It is based on hybrid capture technology and therefore enables the detection of unknown gene fusions.

Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.
Product Order no.
AmoyDx® Comprehensive Panel ADX-NCP04-R
AmoyDx® Essential NGS Panel ADX-NLC01
AmoyDx® FGFR1-4 NGS Panel ADX-NFP08-R
AmoyDx® HRR Liquid NGS Panel ADX-NHLP10-R
AmoyDx® Master Panel ADX-NMP07-R

Advantages of the AmoyDx® ddCAP kits

  • Detection of unknown gene fusion partners

  • UID-sequences (unique identifier sequences) efficiently identify PCR errors during data analysis

  • Sequencing data analysis on the AmoyDx® ANDAS workstation, a cloud-independent stand-alone system for high data security

  • Suitable for many common Illumina sequencing platforms

Product availability

Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.

Got it